Analyst Ratings For GlaxoSmithKline (LON:GSK)
Today, GlaxoSmithKline (LON:GSK) stock received an upgrade by Barclays from Overweight with a price target of GBX 1,650.
Some recent analyst ratings include
- 1/17/2018-Barclays Upgrade from a “Overweight” rating to a “” rating.
- 1/16/2018-Jefferies Group Reiterated Rating of Buy.
- 1/16/2018-BNP Paribas Reiterated Rating of Neutral.
- 1/15/2018-Liberum Capital Reiterated Rating of Buy.
- 12/13/2017-Berenberg Bank Reiterated Rating of Buy.
Recent Trading Activity for GlaxoSmithKline (LON:GSK)
Shares of GlaxoSmithKline closed the previous trading session at 1,364.60 up +9.60 0.71% with 38.189998626708984 shares trading hands.